A recent study conducted by the University of Freiburg has raised concerns about the use of aspirin, particularly in individuals who are at risk of...
Vous n'êtes pas connecté
A recent study conducted by the University of Freiburg has raised concerns about the use of aspirin, particularly in individuals who are at risk of developing heart failure. Aspirin is commonly known for its pain-relieving and anti-inflammatory effects and is also prescribed to prevent heart attacks and strokes in certain groups. However, this new research […]
A recent study conducted by the University of Freiburg has raised concerns about the use of aspirin, particularly in individuals who are at risk of...
A recent study by scientists at McGill University has raised concerns about the common use of anti-inflammatory drugs and steroids to relieve pain....
A recent study by scientists at McGill University has raised concerns about the common use of anti-inflammatory drugs and steroids to relieve pain....
A new study has found that statin medications, commonly used to prevent heart attacks and strokes, are both cost-effective and linked to better health...
A new study has found that statin medications, commonly used to prevent heart attacks and strokes, are both cost-effective and linked to better health...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
A World Health Organization review of 63 studies conducted between 1994 and 2022 found no link between mobile phone use and brain cancer. The study...
The 22nd Nigeria's Chief of Army Staff, LIEUTENANT GENERAL TAOREED ABIODUN LAGBAJA recently delivered a lecture at the Third Strategic Counter...
Scientists from Western University have discovered a promising molecule found in sweet oranges and tangerines called nobiletin, which may help combat...